These Top 9 Companies Are Revolutionizing the Catheter Market in 2025

The catheter market was valued at USD 58.27 billion in 2024. It is anticipated to grow at a CAGR of 6.60% during the forecast period of 2025-2034, with the values likely to reach USD 110.41 billion by 2034. The market is driven by the increasing prevalence of chronic diseases and innovations in catheter designs across the globe.

A catheter is a flexible medical device inserted into the body to perform diagnostic or therapeutic procedures. It is commonly used to drain fluids, administer medication, or monitor bodily functions. Catheters are typically made from materials like silicone, polyurethane, or PVC, ensuring compatibility with the human body. They are used in various medical fields, including urology, cardiology, and anesthesia, to enhance patient care and facilitate minimally invasive procedures.

The global catheter market is expanding rapidly, driven by increasing demand for minimally invasive surgeries and advancements in medical technology. Factors such as rising healthcare awareness, growing aging populations, and the increasing prevalence of chronic diseases contribute to market growth. The market is also supported by innovations in catheter designs, such as antimicrobial coatings and improved materials, which enhance patient safety and comfort.

In January 2024, Penumbra, Inc. launched its Indigo system CAT RX catheter in Europe, receiving CE Mark approval for treating acute coronary syndrome (ACS). This continuous aspiration thrombectomy catheter is designed to improve thrombus removal and myocardial perfusion, addressing key limitations of traditional ACS therapies such as delayed reperfusion and incomplete clot extraction. By enhancing the effectiveness and safety of thrombectomy procedures, the device is poised to significantly contribute to the growth of the global catheter market.

Let’s explore the profile of top companies leading the global catheter market in 2025.

1.    Hollister Inc.

Hollister Incorporated stands as a global leader in the medical device industry, providing a diverse selection of healthcare products, including intermittent catheters for managing continence. The company's catheter lines, such as the VaPro, Apogee, and Advance Plus, focus on promoting ease of use, comfort, and hygiene. Hollister's innovative approach, featuring its No Touch technology, enhances user experience while minimizing the risk of infection during catheterization.

2.    Medtronic Plc

Medtronic, a major player in the medical devices market, offers an extensive array of catheter solutions, particularly within the cardiovascular field. Their product portfolio includes advanced guide catheters, aspiration catheters, and coronary intervention solutions like the Launcher and Export series. Medtronic emphasizes cutting-edge technology to improve procedural efficiency, patient outcomes, and clinician convenience during complex procedures.

3.    Coloplast AS

Coloplast, a medical devices company, specializes in catheter products. Their offerings include SpeediCath and Self-Cath closed systems, designed to simplify self-catheterization while maintaining high hygiene standards. Coloplast focuses on promoting patient comfort and independence by providing easy-to-use, ready-to-use solutions for bladder management and urological care.

4.    Becton, Dickinson and Company

BD is known for its top-tier medical devices, including polyurethane ureteral catheters.These single-use catheters are crafted for efficient ureteral access, offering flexibility, smooth shafts, and color-coded ends for easy identification. BD’s catheters are radiopaque, sterile, and available in various sizes and configurations to ensure patient comfort and precision during medical procedures.

5.    B. Braun Melsungen AG

B. Braun is a leading name in the global catheter market, providing an extensive range of urinary catheters, including intermittent, indwelling, and suprapubic types. Their Actreen product line offers solutions for male, female, and pediatric self-catheterization, with a focus on comfort and user-friendliness. B. Braun’s commitment to innovation ensures reliable and hygienic options for patients requiring catheterization.

6.    Abbott Laboratories

Abbott is a key player in the medical field, offering advanced solutions for pacing and defibrillator procedures. Their CPS Locator 3D catheter is designed for precise left bundle branch area pacing, while the CPS Aim Universal II catheters support coronary sinus cannulation and left ventricular lead delivery. Abbott’s innovative tools enhance procedural control and improve patient outcomes during complex cardiac interventions.

7.    Boston Scientific Corporation

Boston Scientific is a prominent company in the market, specializing in diagnostic and therapeutic catheters. Their Imager II Angiographic Catheter features a highly radiopaque tip for superior visualization and a flexible, tapered design that ensures smooth wire transitions. With its Medi-Glide coating, the catheter improves insertion and tracking, providing precise access and reducing trauma during medical procedures.

8.    Teleflex Incorporated

Teleflex Incorporated is a leader in medical technologies, offering a comprehensive range of catheter products, including indwelling catheters, Foley catheters, and pediatric catheters. These solutions address various medical needs in urology, bladder management, and gynecology. Teleflex's dedication to innovation and quality ensures healthcare professionals have access to dependable, sterile, single-use devices for effective patient care.

9.    Johnson & Johnson Services, Inc.

Johnson & Johnson MedTech is a key player in the catheter market, particularly with innovative solutions for neurovascular care. In February 2025, the company introduced the Cereglide 92 Catheter System, designed for acute ischemic stroke procedures. This next-generation catheter offers superior flexibility and flow control, aiding physicians in overcoming anatomical challenges during thrombectomy. It is part of Johnson & Johnson’s expanding portfolio focused on improving stroke treatment outcomes.